Connect with us

Hi, what are you looking for?

AI Generative

MiniMax Prices Hong Kong IPO at HK$165, Aiming for US$538M amid AI Boom

MiniMax targets US$538M by pricing its Hong Kong IPO at HK$165 per share, reflecting strong demand amid China’s AI sector boom.

MiniMax is poised to raise at least HK$4.2 billion (approximately US$537.7 million) by pricing its initial public offering (IPO) in Hong Kong at the top of its marketed range. This move highlights the robust demand for companies in China’s rapidly evolving artificial intelligence sector, particularly as competition with the United States intensifies. The Shanghai-based firm, supported by major investors Alibaba Group Holding and Tencent Holdings, intends to price its 25.4 million shares at HK$165 each, according to sources familiar with the details. Orders from institutional investors will close at 5 PM on Monday, a day earlier than initially planned.

The heightened interest from institutional investors in the international tranche, which constitutes 95 percent of the total offering, may prompt MiniMax to consider expanding its IPO to as high as HK$4.8 billion. The company is expected to commence trading on the Hong Kong Stock Exchange on Friday, signaling a significant development in the local tech landscape.

A representative from MiniMax declined to provide further comment on the IPO. The anticipated fundraising comes at a time when numerous Chinese AI and technology firms are looking to capitalize on favorable market conditions, bolstered by support from the Chinese government for its domestic tech industry.

MiniMax’s upcoming listing coincides with the IPOs of its peers, including Zhipu AI, which is set to list on Thursday, alongside Shanghai Iluvatar CoreX Semiconductor, a maker of general-purpose graphics processing units, and Edge Medical, known for its surgical robots. Collectively, these companies are expected to raise around HK$9.2 billion through their IPOs.

Investors are keenly observing these developments, as the performance of these listings could reflect broader trends in the tech sector and investor sentiment towards AI companies in the wake of Beijing’s ongoing support. Recent estimates from PwC indicate that firms could raise as much as HK$350 billion from IPOs in Hong Kong this year alone, underscoring the vibrant market conditions.

As the race in the AI sector heats up, particularly between China and the U.S., companies like MiniMax are strategically positioning themselves to attract investment and capitalize on advancements in technology. The outcome of this IPO could serve as a barometer for investor confidence in the Chinese tech industry as it continues to grow and evolve in a competitive global environment.

See also
Staff
Written By

The AiPressa Staff team brings you comprehensive coverage of the artificial intelligence industry, including breaking news, research developments, business trends, and policy updates. Our mission is to keep you informed about the rapidly evolving world of AI technology.

You May Also Like

AI Regulation

Over 200 bills targeting data centers emerged across all 50 states in 2025, reshaping regulations on energy, water, and environmental concerns amid the AI...

AI Research

U.S. energy demands for AI data centers could surge by 47 GW by 2030, necessitating a renewed focus on nuclear power's pivotal role in...

AI Generative

OpenAI faces defamation lawsuits in multiple countries, as generative AI's false outputs provoke significant legal challenges and reputational risks for public figures.

Top Stories

DeepSeek-R1 outshines Doubao-1.5-pro with 98% excellence in ovarian cancer care evaluation, demonstrating superior alignment with clinical guidelines.

AI Cybersecurity

Anthropic's Claude Code Security uncovers over 500 vulnerabilities, triggering sharp declines in cybersecurity stocks like JFrog by 24% and CrowdStrike by 10%

Top Stories

China's MiniMax and Zhipu stocks soar over 500% as investors flock to AI leaders, igniting a transformative investment boom in the tech sector.

AI Research

China's DeepRare AI system achieves over 70% diagnostic accuracy for rare diseases, revolutionizing patient care and addressing critical healthcare challenges.

AI Government

Human Rights Watch's Philippe Bolopion warns that AI's misuse by autocratic regimes poses a growing threat to global human rights amid worsening democratic decline.

© 2025 AIPressa · Part of Buzzora Media · All rights reserved. This website provides general news and educational content for informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the information presented. The content should not be considered professional advice of any kind. Readers are encouraged to verify facts and consult appropriate experts when needed. We are not responsible for any loss or inconvenience resulting from the use of information on this site. Some images used on this website are generated with artificial intelligence and are illustrative in nature. They may not accurately represent the products, people, or events described in the articles.